Opinion

Podcast

Advancing the State of Precision Medicine in Rheumatoid Arthritis

Expert rheumatologists discuss precision medicine in rheumatoid arthritis. In particular, they discuss available data and the value of various tools in guiding treatment selection in routine clinical practice.

To watch the video series component of this episode, click here.

0:00 Introduction

01:29 Precision Medicine in Rheumatoid Arthritis (RA)

03:34 Biomarkers and Diagnostic Tools in RA

07:08 Science Behind Molecular Signature Response Classifier (MSRC) Test

08:30 Accelerate Information of Molecular Signatures (AIMS) Study

10:33 Experience with MSRC Test in Clinical Practice

12:46 Heterogeneity of RA and Development of Other Biomarkers in RA

14:49 MSRC Test Coverage by Medicare and Future of Precision Medicine in RA

17:54 Safe Step Act in RA Management and Success in Utilization of Precision Medicine

20:48 Final Thoughts and Recap of Discussion

Related Videos
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
© 2024 MJH Life Sciences

All rights reserved.